Medical review is required when content interprets clinical or health research, discusses a condition or symptom in a decision-making context, addresses safety or interactions, or could reasonably be understood as medical guidance.

A general marketing article does not receive medical schema or reviewer attribution simply because cannabis or CBD is mentioned.

The author is the person or organization that created the article. The medical reviewer checks the relevant health information for accuracy, balance, limitations, and risk of misinterpretation.

A reviewer is named only after approving the final reviewed version. The review date is recorded.

The reviewer may check whether medical statements accurately reflect the cited source, whether limitations are visible, whether the content avoids diagnosis or personalized treatment advice, and whether commercial product claims extend beyond the evidence.

Medical review does not replace legal or regulatory review of cannabis promotion.

Reviewer profiles should present verifiable credentials relevant to the work, external reference links where available, and a clear description of the reviewer role.

Philip W. Askenase, MD, is listed as an Allergy & Immunology specialist and Yale University School of Medicine graduate based on the supplied WebMD profile.

Articles do not diagnose readers, prescribe treatment, provide individualized dosage, replace professional care, or guarantee a health outcome.

Readers should consult an appropriately qualified health professional for personal medical questions.

Health-related articles should be re-reviewed after a material source or policy change, a substantive correction, or an update that changes the medical interpretation.

Reviewer attribution may be removed when approval cannot be documented for the current version.